25 body irradiation, and allogeneic marrow transplantation. Blood, 1977, 49:511-33. 34. Thomas ED, Buckner CD, Clift RA, Fefer A, Johnson FL, Neiman PE, Sale GE, Sanders JE, Singer JW, Shulman H, Storb R, Weiden PL: Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N Engl J Med 1979, 301:597-9. 35. Beutler E, Blume KG, Bross KJ, Chillar RK, Ellington OB, Fahey JL, Farbstein MI, Schmidt GM, Spruce WE, Turner MA: Bone marrow transplantation as the treatment of choice for “good risk” adult patients with acute leukemia. Trans Assoc Am Physicians, 1979, 92:189-95. 36. Weiden PL, Flournoy N, Thomas ED, Prentice R, Fefer A, M.D., Buckner CD, Storb R, Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med, 1979, 300:1068–73. 37. Saral R, William HB, Laskin OL, Santos GW, and Lietman PS, Acyclovir Prophylaxis of Herpes-Simplex-Virus Infections — A Randomized, Double-Blind, Controlled Trial in Bone-Marrow-Transplant Recipients. N Engl J Med, 1981, 305: 63-67. 38. Kay HE, Powles RL, Sloane JP, Farthing MG., Cyclosporin A in human bone marrow grafts. Haematol Blood Transfus. 1980, 25:255–60. 39. Deeg HJ, Storb R, Weiden PL, Raff RF, Sale GE, Atkinson K, Gra - ham TC, Thomas ED: Cyclosporin A and methotrexate in canine marrow transplantation: engraftment, graft-vs.-host disease, and induction of tolerance. Transplantation 1982, 34:30-5. 40. Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Doney K, Farewell V, Hansen JA, Hill R, Lum L, Martin P, McGuffin R, Sanders JE, Sullivan K, Witherspoon R, Yee G, Thomas ED: Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft vs. host disease after marrow transplantation for leukemia. N Engl J Med 1986, 314:729-35. 41. Hansen JA, Clifl RA, Thomas ED , Buckner CD, Storb R, Giblett ER, Transplantation of marrow from an unrelated donor to a patient with acute leukemia. N Engl J Med, 1980, 303:565-567. 42. Clift RA, Buckner CD, Thomas ED, Doney K, Fefer A, Neiman PE, Singer J, Sanders J, Stewart P, Sullivan KM, Deeg J, Storb R: Treatment of chronic granulocytic leukaemia in chronic phase by allogeneic marrow transplantation. Lancet, 1982, 2: 621-3. 43. Goldman JM, Baughan AS, McCarthy DM, Worsley AM, Hows JM, Gordon-Smith EC, Catovsky D, Batchelor JR, Goolden AW, Galton DA: Marrow transplantation for patients in the chronic phase of chronic granulocytic leukaemia, Lancet 1982, 2:623-5. 44. Goldman JM, Apperley JF, Jones L, Marcus R, Goolden AWG, Batchelor R, Hale G, Waldmann H, Reid CD, Hows J, Gordon-Smith E, Catovsky D, Galton DAG: Bone marrow transplantation for patients with chronic myeloid leukemia. N Engl J Med, 1986, 314:202-7. 45. Thomas ED, Clift RA, Fefer A, Appelbaum FR, Beatty P, Bensinger WI, Buckner CD, Cheever MA, Deeg HJ, Doney K, Flourney N, Greenberg P, Hansen JA, Martin P, McGuffin R, Ramberg R, Sanders JE, Singer J, Stewart P, Storb R, Sullivan K, Weiden PL, Witherspoon R: Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Intern Med, 1986, 104:15563. 46. Thomas ED, Buckner CD, Sanders JE, Papayannopoulou T, Borgna Pignatti C, De Stefano P, Sullivan KM, Clift RA, Storb R: Marrow transplantation for thalassaemia. Lancet 1982, 2: 227-9. 47. Lucarelli G., Galimberti M., Polchi P., Angelucci E., Baronciani D., Giardini C., Politi P., Durazzi S.M., Muretto P., Albertini F. Bone marrow transplantation in patients with thalassemia. N Engl J Med,1990, 322:417–421. 48. Johnson FL, Look AT, Gockerman J, Ruggiero MR, Dalla Pozza L, Billings FT, III: Bone marrow transplantation in a patient with sickle cell anemia. N Engl J Med, 1984, 311:780-3. 49. Tutschka PJ, Copelan EA, Klein JP, Bone Marrow Transplantation for Leukemia Following a New Busulfan and Cyclophosphamide Regimen. Blood, 1987, 70, 5: 1382-1388. 50. Santos GW: Busulfan (Bu) and Cyclophosphamide (Cy) for marrow transplantation. Bone Marrow Transplant, 1989, 4: 236-9. 51. Juttner CA, To LB, Ho JQK, Bardy PG, Dyson PG, Haylock DN, Kimber RJ: Early lympho-hemopoietic recovery after autografting using peripheral blood stem cells in acute non-lymphoblastic leukemia. Transplant Proc, 1988, 20:40-2. 52. Gianni AM, Siena S, Bregni M, Tarella C, Stern AC, Pileri A, Bonadonna G: Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation Lancet 1989, 2: 580-5. 53. Gluckman E, Broxmeyer HE, Auerbach AD, Friedman HS, Douglas, GW, Devergie A, Esperou H, Thierry D, Socié G, Lehn P, Cooper S, English D, Kutzberg J, Bard J, Boyse E: Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989, 321:1174-8. 54. Schmidt GM, Horak DA, Niland JC, Duncan SR, Forman SJ, Zaia, J A : A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. N Engl J Med, 1991, 324: 1005-11. 55. Goodrich JM, Mori M, Gleaves CA, Du Mond C, Cays M, Ebeling DF, Buhles WC, DeArmond B, Meyers JD: Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med, 1991, 325:1601-7. 56. Kolb HJ, Mittermtiller J, Clemm Ch, Holler G, Ledderose G, Brehm G, Heim M, Wilmanns, W: Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990, 76: 2462-5. 57. Papadopoulos EB, Ladanyi M, Emanuel D, Mackinnon S, Boulad F, Carabasi MH, Castro-Malaspina H, Childs BH, Gillio AP, Small TN, Young JW, Kernan NA, O’Reilly RJ: Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med, 1994, 330:1185-91. 58. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, Gajewski J, Hansen JA, Henslee-Downey J, McCullough J, McGlave P, Perkins HA, Phillips GL, Sanders J, Stroncek D, Thomas ED, Blume KG: Analysis of 462 transplantations from unrelated donors facilitated by The National Marrow Donor Program. N Engl J Med, 1993, 328:593-602. 59. Hansen JA, Gooley TA, Martin PJ, Appelbaum F, Chauncey TR, Clift RA, Petersdorf EW, Radich J, Sanders JE, Storb RF, Sullivan KM, Anasetti C: Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med, 1998, 338: 962-8. 60. Giralt S, Estey E, Albitar M, van Besien K, Rondón G, Anderlini P, O’Brien S, Khouri I, Gajewski J, Mehra R, Claxton D, Andersson B, Beran, M, Przepiorka D, Koller C, Kornblau S, Korbling M, Keating M, Kantarjian H, Champlin R: Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-vs.-leukemia without myeloablative therapy. Blood, 1997, 89: 4531-6. 61. Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Apperley J, Slavin S, Pasquini M, Sandmaier BM, Barrett J, Blaise D, Lowski R, Horowitz M, Defining the Intensity of Conditioning Regimens: Working Definitions. BBMT 2009, 15, 12: 1628-1633. 1. Aspetti Generali
RkJQdWJsaXNoZXIy ODUzNzk5